Repurposing Navitoclax to block SARS‐CoV‐2 fusion and entry by targeting heptapeptide repeat sequence 1 in S2 protein
Work
Year: 2023
Type: article
Source: Journal of Medical Virology
Institutions Fudan University, National Academy of Sciences of Belarus, Institute of Bioorganic Chemistry, United Institute of Informatics Problems
Cites: 53
Cited by: 6
Related to: 10
FWCI: 1.976
Citation percentile (by year/subfield): 77.01
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: closed